REVISED DOUBLE ANTIBODY AMPHETAMINE

Radioimmunoassay, Amphetamine

DIAGNOSTIC PRODUCTS CORP.

The following data is part of a premarket notification filed by Diagnostic Products Corp. with the FDA for Revised Double Antibody Amphetamine.

Pre-market Notification Details

Device IDK882228
510k NumberK882228
Device Name:REVISED DOUBLE ANTIBODY AMPHETAMINE
ClassificationRadioimmunoassay, Amphetamine
Applicant DIAGNOSTIC PRODUCTS CORP. 5700 WEST 96TH ST. Los Angeles,  CA  90045 -5597
ContactKenneth B Asarch
CorrespondentKenneth B Asarch
DIAGNOSTIC PRODUCTS CORP. 5700 WEST 96TH ST. Los Angeles,  CA  90045 -5597
Product CodeDJP  
CFR Regulation Number862.3100 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1988-05-19
Decision Date1988-08-08

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.